STRESSED ABOUT STRESS TESTS

Similar documents
My Patient Needs a Stress Test

I have no financial disclosures

Chest Pain Wave I. Making Dollars and Sense Out of Stress Testing

Current and Future Imaging Trends in Risk Stratification for CAD

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

Simon A. Mahler MD, MS, FACEP Associate Professor Department of Emergency Medicine Wake Forest School of Medicine

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

High Value Evaluation of Chest Pain. Zoom Tips

The Value of Stress MRI in Evaluation of Myocardial Ischemia

CHRONIC CAD DIAGNOSIS

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

DIAGNOSTIC TESTING IN PATIENTS WITH STABLE CHEST PAIN

. θωρακικούάλγουςστα εξωτερικά ιατρεία

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018

Risk Stratification for CAD for the Primary Care Provider

NUCLEAR CARDIOLOGY UPDATE

CHEST PAIN CDU INCLUSION CRITERIA

Exercise Test: Practice and Interpretation. Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

The use of Cardiac CT and MRI in Clinical Practice

CASE from South Korea

Maria Angela S. Cruz-Anacleto, MD

Welcome! To submit questions during the presentation: or Text:

Case Question. Evaluation of Chest pain in the Office and Cardiac Stress Testing

Stress Testing:Which Study is Indicated for My Patient?

Choosing the Right Cardiac Test. Outline

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

The Emerging Role of Cardiac CT in Cardiovascular Imaging. Anthony Gemignani, MD Vermont Cardiac Network April 28, 2016

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

Long-term outcome after normal myocardial perfusion imaging in suspected ischaemic heart disease

Clinical Investigations

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010

Stress echo workshop STRESSORS

Chest Pain in Women ;What is Your Diagnostic Plan? No Need for Noninvasive Test

Is computed tomography angiography really useful in. of coronary artery disease?

Effect of intravenous atropine on treadmill stress test results in patients with poor exercise capacity or chronotropic incompetence ABSTRACT

Patient characteristics Intervention Comparison Length of followup

2/17/2010. Grace Lin, MD Assistant Professor of Medicine University of California, San Francisco

Atypical pain and normal exercise test

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice

Non Invasive Diagnostic Modalities for Coronary Artery Disease. Dr. Amitesh Aggarwal

Non ST Elevation-ACS. Michael W. Cammarata, MD

Guideline Number: NIA_CG_024 Last Review Date: January 2011 Responsible Department: Last Revised Date: May 2, 2011 Clinical Operations

Proper risk stratification is critical for the management of

FFR-CT Not Ready for Primetime

Disclosure Information

Normal Stress-Only Versus Standard Stress/Rest Myocardial Perfusion Imaging

Test in Subjects with Suspected CAD Anatomic Study is Better

The Role of Computed Tomography in the Diagnosis of Coronary Atherosclerosis

Stress tests: How to make a calculated choice Spare your patients unnecessary stress testing by determining their pretest probability for CAD

Family Practice. Stress tests: How to make a calculated choice. For personal use only. Copyright Dowden Health Media

Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis.

Value of Stress Myocardial Perfusion Single Photon Emission Computed Tomography in Patients With Normal Resting Electrocardiograms

Cardiac Stress Test [ ] Procedures. Cardiac Studies Stress Tests (Single Response)

Prior research has revealed that event rates associated

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

Evidence for Everyone: Expanding the Reach of Health Technology Assessment 2016 CADTH Symposium, April 10-12, Shaw Centre, Ottawa

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Journal of the American College of Cardiology Vol. 50, No. 11, by the American College of Cardiology Foundation ISSN /07/$32.

Cardiac CT Angiography

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

9/2/2016 CARDIOLOGY TESTING WHAT TO ORDER WHEN REFERENCE OBJECTIVES

FFR Incorporating & Expanding it s use in Clinical Practice

Rational use of imaging for viability evaluation

Cardiology Updates: Syncope and Stress Testing. Kathleen Morris, DO Cardiology Fellow St. Vincent Hospital

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh

Angina Luis Tulloch, MD 03/27/2012

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Prognostic utility of ischemic response in functional imaging tests (SPECT or stress echocardiography) in low-risk unstable angina patients

Troponin = 35. Objectives. Low Risk Chest Pain. Does this patient have ACS? Does this patient have ACS? Objectives

P F = R. Disorder of the Breast. Approach to the Patient with Chest Pain. Typical Characteristics of Angina Pectoris. Myocardial Ischemia

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

When Should I Order a Stress Test or an Echocardiogram

Patient-centered Imaging in Coronary Artery Disease. Jason H Cole, MD, MS, FACC January 10, 2015

Diagnostic and Prognostic Value of Coronary Ca Score

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

Multimodality Imaging in Spontaneous Coronary Artery Dissection in the Peripartum Period

The elderly aged 75 years constitute 6% of the US

Diagnosis of CAD S Richard Underwood

STEMI, Non-STEMI, Chest Pain?

What the Cardiologist needs to know from Medical Images

Pearls & Pitfalls in nuclear cardiology

Cardiac Stress MRI: Detection of Ischemia. Disclosures: Dobutamine Stress MR. April 28, 2018

Acute Coronary Syndrome. Sonny Achtchi, DO

Stress only Perfusion Imaging

Should the attainment of predicted heart rate maximum be used as an exercise test end point?

2017 Qualified Clinical Data Registry (QCDR) Performance Measures

The diagnostic role of stress echocardiography in women with coronary artery disease: evidence based review John R. McKeogh

HEART CONDITIONS IN SPORT

Subha V. Raman, MD, MSEE, FACC, FAHA

History of Stress Testing. Disclosure. Overview. Stress Echocardiography New Applications. and Comparison with Other Stress.

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

PET for the Evaluation of Myocardial Viability

Benoy N Shah 1,2,3, Gothandaraman Balaji 1, Abdalla Alhajiri 1, Ihab Ramzy 1, Shahram Ahmadvazir 1 & Roxy Senior 1,2,3

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events

A Prognostic Score for Prediction of Cardiac Mortality Risk After Adenosine Stress Myocardial Perfusion Scintigraphy

Click here for Link to References: CMS Website HOPPS CY 2018 Final Rule. CMS Website HOPPS CY2018 Final Rule Updated November 2017.

EMPHISIS ON PHYSIOLOGY PHYSIOLOGY REQUIRES TIME QUALITATIVE vs. QUANTITATIVE ISOTOPES TO RADIOPHARMACEUTICALS

Transcription:

STRESSED ABOUT STRESS TESTS Problem Based Lecture Jennifer W. Hsieh Department of Emergency Medicine PGY-3

Question 6 What is the diagnostic accuracy of cardiac testing in low risk chest pain patients? What is the prognostic value of negative provocative testing and negative cardiac imaging?

The Bigger Question Do we need to evaluate low risk chest pain patients in the ED with provocative testing?

Objectives Overview of several modalities available for confirmatory cardiac testing- with Dr. Pflaum Review of literature regarding the accuracy and prognostic values of these tests Exercise Treadmill Test (ETT) Myocardial Perfusion Index (MPI) Stress ECHO Coronary CT Angiography (CCTA) Will NOT discuss cardiac MRI, PET and Catheterization

The Sources

The Sources

What is Exercise Treadmill Testing? Patient exercises on treadmill under supervision of trained professional Monitored for abnormalities suggesting exercise induced ischemia Symptoms EKG changes Blood pressure Arrhythmias Must achieve adequate heart rate of at least 85% agepredicted maximum

From nhlbi.nih.gov

What is an MPI? Nuclear study used to detect abnormalities in myocardial perfusion (SPECT) Thallium-201 Technetium Tc 99m Sestamibi (Cardiolite), tetrofosmin (Myoview) Rest vs. Stress Irreversible (infarction) vs. reversible (ischemia) Exercise vs. chemical stress Hand grip, treadmill, vasodilator (dipyridamole, adenosine, regadenoson)

Quantitative analysis vs. expert visual analysis From Braunwald s: figure 17-26

What is a Stress ECHO? ECHO obtained after stress, compared to ECHO at rest to detect wall motion abnormalities and perfusion defects suggestive of inducible ischemia Exercise vs. chemical stress Treadmill, bicycle, dobutamine, dipyridamole, adenosine

From Braunwald s: figure 13-35

What is CT Coronary Angiography? High resolution CT imaging of coronary arteries From Braunwald s: figure 19-13

Coronary Artery Calcium Scanning Uses coronary calcium as marker for atherosclerosis From Braunwald s: figure 19-10

What to Order When?

How Good is Exercise Treadmill Testing? Braunwald s Sensitivity 68%, Specificity 77% for patient s selected to undergo angiography Several series of clinically low-risk subjects have reported 6 month cardiac event rates lower than 1% with a normal exercise test result.

Duke Treadmill Score Prognosis related to the Duke Treadmill Score Exercise duration Degree of ST segment deviation Presence/severity of angina DTS= exercise time - (5xST deviation) - (4xangina)

Duke Treadmill Score and Survival 5 year mortality Low risk: 3% Moderate risk: 10% High risk 35% UpToDate

Studies of Exercise Treadmill Testing in Accelerated Diagnostic Protocols

Objective To determine the safety and accuracy of immediate exercise testing in low risk patients presenting to the emergency department with chest pain suggestive of a cardiac etiology.

Study Design Single center prospective trial Patients n = 1,000 Considered low clinical risk (hemodynamically stable, no arrhythmias, no evidence of acute cardiopulmonary process on exam, CXR, EKG) Could have persistent pain

Study Design Testing Performed by trained attending internists immediately after initial evaluation +/- one troponin Modified Bruce protocol If negative, discharged; if positive admitted; if non-diagnostic some discharged, some admitted to chest pain unit (34% got further work-up)

Study Design Follow-up At 30 days (review of medical record, phone, mailed questionnaires, coroner s records, social security death index) Overall obtained 89% follow-up (85% clinically, additional 4% due to presence of additional testing)

Results No adverse effects from testing No mortality in any patient Negative in 64%, positive in 12.5%, nondiagnostic in 23.5%

Event rates/diagnosis of CAD: 0.3% in negatives 29% in positives (RR =114) 13% in non-diagnostics (RR = 38)

Conclusions Immediate exercise testing of patients presenting to the ED with chest pain and evidence of low clinical risk is safe and accurate for determining those who require admission and those who can be discharged to further outpatient evaluation.

Limitations What happened to the patients lost to follow-up? (58 negatives, 29 positives, 52 non-diagnostics lost to follow-up) No long-term follow-up: benefits of CAD detection/revascularization unclear Outcome measures of MI, revascularization and diagnosis of CAD No serial troponins

My Conclusions

If Then

How Good is an MPI? Braunwald s Cites 2003 ACC/AHA/ASNC Radionuclide Imaging Guidelines Sensitivity 87% (71-97%), specificity 73% (36%-100%) Patients with normal study have 0.7% rate of MI/cardiac death over 2 years When CAD present with stable symptoms patients with normal study have 0.9% cardiac events/year

Diagnostic Accuracy of Rest MPI in Patients with Acute Chest Pain and a Nonischemic EKG

Objective To assess whether incorporating acute resting perfusion imaging into an ED evaluation strategy for patients with suspected acute ischemia but no initial ECG changes diagnostic of acute ischemia improves clinical decision making for initial ED triage.

Study Design Multi-center prospective randomized controlled trial Patients: n = 2475 7 academic medical centers and community hospitals 30 years or older (18 years or older if + cocaine) with symptoms suggesting acute ischemia within 3 hours and with normal/nondiagnostic initial EKG Patients with history of MI excluded

Study Design Randomization Usual strategy vs. usual strategy + results from scan (rest MPI using SPECT) 47% women in scan group, 51% usual care (p 0.03) otherwise no statistical difference between groups in terms of demographics and risk factors Testing Scan patients quickly injected with sestamibi Imaged 30 min + after injection Results reported to ED physician (normal, abnormal, equivocal) as soon as available who used data in determining disposition

Study Design Final diagnosis ECGs, cardiac enzymes, follow-up stress testing for all Admitted: in hospital Discharged: 24-36 hours later Final diagnosis determined by site PI (blinded) Follow-up At 30 days: for vital status, cardiac events, need for procedure 99% complete

Results 13% with acute ischemia (2% AMI, 11% UA) No difference in appropriate hospitalization rates for patients with UA/AMI 1 missed AMI in each group (p=0.92) 26 missed UA in scan group, 23 in usual care (p=0.58) No difference in outcomes at 30 days Fewer unnecessary hospitalizations in scan group- 42% vs. 52% (RR 0.84%, 95% CI 0.77-0.92, P< 0.001)

Results No difference in outcomes at 30 days

Results MPI results had prognostic value Risk AMI at 30 days 0.6% in normals, 0.8% in equivocals, 10.3% in abnormals (RR 6.61 for equivocal/abnormal compared to normal, p < 0.001) Risk cardiac event at 30 days 3.0% in normals, 6.1% in equivocals, 20.5% in abnormals (RR 3.83 for equivocal/abnormal compared to normal, p <0.001)

Conclusions Sestamibi perfusion imaging improves ED triage decision making for patient with symptoms suggestive of acute cardiac ischemia without obvious abnormalities on ECG. In this study, unnecessary hospitalizations were reduced among patients without acute ischemia, without reducing appropriate admission for patients with acute ischemia.

Limitations End-point of study is appropriateness of ED disposition decision- assumes only reason to admit is to rule out ACS Diagnosis of ACS/MI may not be objective No long-term follow-up End-points for cardiac events: death, MI, revascularization

My Conclusions Well executed study to answer question of whether rest MPI helps with patient disposition in the ED Demonstrates good short-term prognostic value of negative rest MPI

How Good is a Stress ECHO? Braunwald s Comparable to nuclear studies Sensitivity 85%, specificity 88% (study?) Cites Mayo Clinic study: event rate of less than 3% at 3 year follow up after a negative study

Predictive Accuracy of Stress ECHO in Patients Presenting to the ED with Chest Pain

Objective We prospectively studied the prognostic value of predischarge dobutamine stress echocardiography in low-risk chest pain patients with a normal or nondiagnostic electrocardiogram and a negative serial troponin T.

Study Design Multi-center prospective double-blind trial Patients n = 377 Patients with chest pain within 6 hours of presentation with a normal/non-diagnostic ECG Excluded: younger than 18, unable to give consent, a-fib, conduction disturbances, severe HTN, severe CHF, requiring resuscitation, serious non-cardiac disease, pregnant Initial evaluation H&P, serial EKG, continuous cardiac monitoring, serial troponins, observation for at least 12 hours

21% with ACS after initial evaluation!

Study Design Testing IV dobutamine given in increasing dose increments per protocol (max 40 mcg/kg/min) End points: severe and/or extensive new wall motion abnormality, target HR, tachyarrhythmias, ECG changes, CP, BP > 240/120 or sbp decrease 40 mmhg, intolerable sideeffects Atropine prn to achieve 85% age predicted maximal heart rate or if endpoints not achieved Beta blocker prn to reverse effects Results reported as positive and negative (read by two experienced investigators, if disagree third read obtained) Positive if new wall motion abnormality in at least 1/16 LV segments

Study Design Follow-up At 6 months, follow-up clinic visit 100% complete End points Primary: cardiac death, nonfatal AMI, rehospitalization for UA Secondary: revascularization

Results

Results 26 positive, 351 negative Target HR achieved in 80.1%; Test not completed in 19.9% (developed exclusion criteria) DSE results had prognostic value: Positive test gives OR of 6.2 (95% CI 1.6-24.3) for primary endpoint and OR of 7.1 (95% CI 2.5-20.2) for combined end point At 6 months risk of cardiac event 30.8% in positive group, 4% in negative group (p < 0.0001)

Conclusions Conclusions: A predischarge DSE had important, independent prognostic value in low-risk, troponin negative, chest pain patients.

Limitations Multiple end-points for cardiac event some more serious that others (e.g. death vs. rehospitalization for UA) Patients are higher risk than what we consider low-risk Non-diagnostic tests categorized as negative

My Conclusions Another confirmatory test with similar sensitivities and specificities to treadmill testing and MPI In practice in the U.S. unlikely only 26/377 (<7%) will be read as positive 4% cardiac event rate in negatives at 6 months may be too high in current U.S. medical climate

How Good is CT Coronary Angiography? Braunwald s Sensitivity 87-99%, specificity 93-96% (Mowatt et. al.) Little information regarding prognosis

Objectives To determine the usefulness of coronary CT in determining whether discharge of patients from the emergency department is safe.

Study Design Multi-center prospective randomized controlled trial Patients n= 1370 5 sites Low-intermediate risk 30 years or older with TIMI score 0-2, no acute ischemia on ECG Excluded non-cardiac etiology of symptoms, co-existing condition requiring admission, negative cath or CCTA in past 1 year, contraindications to CCTA Randomization 2:1 (CCTA:traditional care)

Study Design Testing 64-slice or greater multi-detector CT scanner able to perform ECGsynchronized cardiac studies Beta blocker for HR control, nitroglycerin for coronary artery dilatation per protocols Non-contrast scan for calcium scoring, contrast scan Results classified as: no stenosis, stenosis less than 50%, stenosis of 50-69%, stenosis of 70% or more Significant CAD= 50% or more stenosis of main coronary arteries or first order branch Indeterminate if negative but with inadequately visualized segments All had second troponin drawn prior to discharge

Study Design Follow-up 100% complete Phone follow-up up at least 30 days later Review of records in local hospitals for repeat visits Social Security Death Master File

Results Results of testing

Results Safety CCTA group 10/908 (1%) had MI within 30 days 0% had death within 30 days 0% with negative CCTA had death or MI within 30 days (95% CI 0-0.57) 1 adverse event (bradyarrhythmia) Traditional group 5/462 (1%) had MI within 30 days 0% had death within 30 days 1 adverse event (bradyarrhythmia)

Results More CCTA patients discharged (49.6% vs. 22.7%, 26.8 percentage points, 95% CI 21.4 to 32.2), shorter length of stay More CAD diagnoses in CCTA group (9.0% vs. 3.5%, 5.6 percentage points, 95% CI 0-11.2) No difference in angiography and revascularization rate, ED/cardiology clinic visits or hospitalizations after 30 days

Conclusions Conclusions: A CCTA-based strategy for low-to-intermediate-risk patients presenting with a possible acute coronary syndrome appears to allow the safe, expedited discharge from the emergency department of many patients who would otherwise be admitted.

Limitations 16% randomized to CCTA did not get CT (unable to adequately beta block, transition of care) No long-term follow-up No information regarding potential harms of CCTA

My Conclusions Shows a negative CCTA can be helpful in ED disposition Implications of a positive CCTA yet to be determined

What Do These Tests Add? What is the diagnostic accuracy of cardiac testing in low risk chest pain patients? Not good enough! Reported range of sensitivities for ETT, MPI and ECHO 68-87%; specificities 73-88% ETT MPI Stress ECHO CCTA Sensitivity 68% 87% 85% 87-99% Specificity 77% 73% 88% 93-96%

A test needs to be very sensitive (few false negatives) if we are using it to further risk stratify ACS in a low risk population A test needs to be very specific (few false positives) if we do not want to be overwhelmed by the need to work-up false positives Low accuracy of confirmatory testing reviewed is not good enough to tell us whether low risk patients have ACS- of the ones who test positive most do NOT have ACS.

The primary purpose of confirmatory testing as part of an accelerated diagnostic protocol during CPU observation is to further minimize the likelihood of ACS to a level so low that discharge is safe. - Amsterdam et. al.

What is the prognostic value of negative provocative testing and negative cardiac imaging? Prognosis of low risk chest pain patients is generally good Confirmatory testing can help further reassure that prognosis is excellent and patient can be discharged

Are We Still Stressed About Stress Tests? Do we need to evaluate low risk chest pain patients in the ED with provocative testing?

References Original Articles Amsterdam EA, Kirk JD, Diercks DB, Lewis WR, Turnipseed DS. Immediate exercise testing to evaluate low-risk patients presenting to the emergency department with chest pain. J am Coll Cardiol. 2002;40:251-256. Bholasingh R, Cornel JH, Kamp O, van Straalen JP, Sanders GT, Tijssen JG, Umans VA, Visser CA, de Winter RJ. Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T. J Am Coll Cardiol. 2003;41:596-602. Litt HI, Gatsonis C, Snyder B, Singh H, Miller CD, Entrikin DW, Leaming JM, Gavin LJ, Pacella CB, Hollander JE. CT angiography for safe discharge of patients with possible acute coronary syndromes. N Engl J Med. 2012;366:1393-1403. Shaw LJ, Peterson ED, Shaw LK, Kesler KL, Delong ER, Harrell FE, Muhlbaier LH, Mark DB. Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circulation. 1998;98:1922-1630. Udelson JE, Beshansky JR, Ballin DS, Feldman JA, Griffith JL, Handler J, Heller GV, Hendel RC, Pope JH, Ruthazer R, Spiegler EJ, Woolard RH, Selker HP. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia. JAMA. 2002;288:2693-2700.

References Guidelines AHA Scientific Statement: Testing of Low-Risk Patients Presenting to the Emergency Department with Chest Pain. (2010) ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force of Practice Guidelines. (2003)

References Books Libby, P., & Braunwald, E. (2012). Braunwald's heart disease: A textbook of cardiovascular medicine. Philadelphia: Saunders/Elsevier. Chizner M. (2007). Clinical cardiology made ridiculously simple. Miami: MedMaster.